Evidence map›Paper›PMID 37409145›Full record

ArticleThe Canadian journal of hospital pharmacy2023

Impact of Pharmacist-Provided Education Using New Information Sheets on Activation in Patients Treated with Oral Antineoplastic Drugs (IMPACT-OAD Project).

Karine Almanric, Viviane Le-Nguyen, Sandrine Léger, Walid Nahi, Hugo Ricignuolo, Gabrielle St-Louis, Ariane Cantin, Amélie L'Ecuyer, Nathalie Letarte

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The Canadian journal of hospital pharmacy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Karine Almanric, BPharm, MSc, BCOP, is with the Pharmacy Department, Hôpital Cité-de-la-Santé, Centre intégré de santé et de services sociaux de Laval, Laval, Quebec.
Viviane Le-Nguyen, PharmD, MSc, is with the Pharmacy Department, Hôpital Cité-de-la-Santé, Centre intégré de santé et de services sociaux de Laval, Laval, Quebec.
Sandrine Léger, PharmD, MSc, is with the Pharmacy Department, Hôpital Cité-de-la-Santé, Centre intégré de santé et de services sociaux de Laval, Laval, Quebec.
Walid Nahi, PharmD, MSc, is with the Pharmacy Department, Hôpital Cité-de-la-Santé, Centre intégré de santé et de services sociaux de Laval, Laval, Quebec.
Hugo Ricignuolo, PharmD, MSc, is with the Pharmacy Department, Hôpital Le Royer, Centre intégré de santé et de services sociaux de la Côte-Nord, Baie-Comeau, Quebec.
Gabrielle St-Louis, PharmD, MSc, is with the Pharmacy Department, Hôpital Cité-de-la-Santé, Centre intégré de santé et de services sociaux de Laval, Laval, Quebec.
Ariane Cantin, PharmD, MSc, is with the Pharmacy Department, Hôpital Cité-de-la-Santé, Centre intégré de santé et de services sociaux de Laval, Laval, Quebec.
Amélie L'Ecuyer, BPharm, MSc, is with the Pharmacy Department, Hôpital Cité-de-la-Santé, Centre intégré de santé et de services sociaux de Laval, Laval, Quebec.
Nathalie Letarte, PharmD, MSc, BCOP, is with the Faculty of Pharmacy, Université de Montréal and Centre hospitalier de l'Université de Montréal, Montréal, Quebec.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Oral antineoplastic drugs (OADs) play an increasing role in the treatment of cancer. Patients must have a high degree of understanding and autonomy to manage the numerous adverse effects at home. In Quebec, recommendations have been made for oncology pharmacists to systematically counsel all patients who are starting an OAD. Objective: To measure the impact of education provided by oncology pharmacists on patient activation. Methods: In this prospective, single-centre, observational cohort study, patients starting an OAD received education from oncology pharmacists, who used the 2020 updated version of information sheets from the Groupe d'étude en oncologie du Québec (GEOQ, www.geoq.info). The Patient Activation Measure (PAM-13) questionnaire was used to measure patients' activation before and after the intervention. Results: Of the 43 patients recruited in the intention-to-treat analysis, 41 were included in the modified intention-to-treat analysis. The mean difference between PAM-13 scores before and after the intervention was 2.30 (standard deviation [SD] 11.85) ( Conclusions: The study did not show a clinically meaningful change in patient activation following pharmacist-provided education, according to the updated GEOQ information sheets. Further studies are needed to evaluate these data in a larger population and to determine whether the impact of education persists beyond the first treatment cycle.

Indexed as

oncology pharmacist educationoral antineoplastic drugspatient activation measure

Identifiers

PMID37409145
PMCPMC10284282

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.